Biological Activity of Lenalidomide and Its Underlying Therapeutic Effects in Multiple Myeloma

Lenalidomide is a synthetic compound derived by modifying the chemical structure of thalidomide. It belongs to the second generation of immunomodulatory drugs (IMiDs) and possesses pleiotropic properties. Even if lenalidomide has been shown to be active in the treatment of several hematologic malign...

Descripción completa

Detalles Bibliográficos
Autores principales: Martiniani, Roberta, Di Loreto, Valentina, Di Sano, Chiara, Lombardo, Alessandra, Liberati, Anna Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417169/
https://www.ncbi.nlm.nih.gov/pubmed/22919394
http://dx.doi.org/10.1155/2012/842945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417169/
https://www.ncbi.nlm.nih.gov/pubmed/22919394
http://dx.doi.org/10.1155/2012/842945

Ejemplares similares